[HTML][HTML] Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus
A Kennedy, DB Brown, J Feilchenfeldt… - Journal of …, 2017 - ncbi.nlm.nih.gov
Selective internal radiation therapy (SIRT) with microspheres labelled with the β-emitter
yttrium-90 (Y-90) enables targeted delivery of radiation to hepatic tumors. SIRT is primarily …
yttrium-90 (Y-90) enables targeted delivery of radiation to hepatic tumors. SIRT is primarily …
Metastatic liver disease: indications for locoregional therapy and supporting data
S Shamimi-Noori, CF Gonsalves… - Seminars in …, 2017 - thieme-connect.com
Metastatic liver disease is a major cause of cancer-related morbidity and mortality. Surgical
resection is considered the only curative treatment, yet only a minority is eligible. Patients …
resection is considered the only curative treatment, yet only a minority is eligible. Patients …
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients
KJ Paprottka, F Schoeppe, M Ingrisch… - European journal of …, 2017 - Springer
Purpose To determine pre-therapeutic predictive factors for overall survival (OS) after yttrium
(Y)-90 radioembolization (RE). Methods We retrospectively analyzed the pre-therapeutic …
(Y)-90 radioembolization (RE). Methods We retrospectively analyzed the pre-therapeutic …
Making the case: intra-arterial therapy for less common metastases
Intra-arterial therapies have high antitumor activity for both primary and secondary hepatic
malignancies. Selective infusions allow increased delivery of cytoreductive therapy to the …
malignancies. Selective infusions allow increased delivery of cytoreductive therapy to the …